CreativeOne Wealth LLC acquired a new stake in shares of Aflac Incorporated (NYSE:AFL – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 2,997 shares of the financial services provider’s stock, valued at approximately $335,000.
Other institutional investors and hedge funds have also modified their holdings of the company. Dimensional Fund Advisors LP lifted its stake in Aflac by 6.3% in the second quarter. Dimensional Fund Advisors LP now owns 4,807,079 shares of the financial services provider’s stock valued at $429,319,000 after buying an additional 285,576 shares in the last quarter. APG Asset Management N.V. raised its holdings in Aflac by 1.3% during the second quarter. APG Asset Management N.V. now owns 2,429,316 shares of the financial services provider’s stock worth $202,437,000 after acquiring an additional 31,752 shares in the last quarter. Guinness Asset Management LTD boosted its holdings in shares of Aflac by 3.8% in the 3rd quarter. Guinness Asset Management LTD now owns 2,276,325 shares of the financial services provider’s stock valued at $254,382,000 after buying an additional 83,289 shares during the last quarter. ProShare Advisors LLC grew its position in shares of Aflac by 5.6% in the 2nd quarter. ProShare Advisors LLC now owns 2,220,125 shares of the financial services provider’s stock valued at $198,279,000 after acquiring an additional 117,504 shares during the period. Finally, Truist Financial Corp grew its holdings in Aflac by 26.6% during the second quarter. Truist Financial Corp now owns 1,929,662 shares of the financial services provider’s stock worth $172,338,000 after purchasing an additional 405,847 shares during the period. 67.44% of the stock is currently owned by institutional investors and hedge funds.
Aflac Stock Performance
AFL opened at $111.41 on Tuesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.08 and a current ratio of 0.08. Aflac Incorporated has a 52-week low of $75.07 and a 52-week high of $115.50. The firm has a market cap of $61.89 billion, a P/E ratio of 16.78, a price-to-earnings-growth ratio of 2.18 and a beta of 0.96. The business’s fifty day moving average is $111.23 and its 200-day moving average is $101.63.
Aflac Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Wednesday, February 19th will be paid a dividend of $0.58 per share. This is a boost from Aflac’s previous quarterly dividend of $0.50. This represents a $2.32 annualized dividend and a yield of 2.08%. Aflac’s dividend payout ratio is presently 30.12%.
Analysts Set New Price Targets
Several equities research analysts have issued reports on AFL shares. Barclays began coverage on Aflac in a report on Wednesday, September 4th. They set an “underweight” rating and a $96.00 price target for the company. TD Cowen started coverage on shares of Aflac in a research note on Wednesday, October 9th. They set a “hold” rating and a $102.00 target price for the company. JPMorgan Chase & Co. upped their price target on shares of Aflac from $85.00 to $90.00 and gave the company a “neutral” rating in a research note on Thursday, October 3rd. Truist Financial increased their price target on shares of Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a report on Friday, November 1st. Finally, Piper Sandler boosted their price objective on Aflac from $114.00 to $122.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $97.93.
Read Our Latest Analysis on AFL
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Further Reading
- Five stocks we like better than Aflac
- What to Know About Investing in Penny Stocks
- How to Master Trading Discipline: Overcome Emotional Challenges
- How to Calculate Options Profits
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.